Repurposing Drugs for Cancer Prevention

被引：0
|
作者：
Choradia, Nirmal [1 ]
Szabo, Eva [2 ]
机构：
[1] NCI, NIH, Ctr Canc Res, Med Oncol Serv, Bethesda, MD USA
[2] NCI, Div Canc Prevent, Lung & Upper Aerodigest Canc Res Grp, 9609 Med Ctr Dr,Rm 5E-102, Bethesda, MD 20892 USA
来源：
CANCER JOURNAL | 2024年 / 30卷 / 05期
关键词：
Cancer prevention; chronic diseases; repurposing; SURGICAL ADJUVANT BREAST; PROSTATE-CANCER; CLONAL HEMATOPOIESIS; BOWEL PROJECT; TRIAL; RISK; ASPIRIN; OBESITY; MORTALITY; METFORMIN;
D O I：
10.1097/PPO.0000000000000746
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The development of agents for cancer prevention is a lengthy process requiring a delicate balance between the safety and tolerability of potential interventions and effectiveness in preventing future cancer. Individuals at risk for a specific cancer are frequently at risk for multiple types of cancer as well as other chronic diseases, especially ones associated with aging. Shared environmental exposures, genetic predisposition, metabolic factors, and commonalities in pathogenesis suggest opportunities for combined targeting of cancer and other chronic diseases. Examples discussed here include mechanisms shared between various cancers and obesity, diabetes, and cardiovascular disease.
引用
收藏
页码：345 / 351
页数：7
相关论文
共 50 条
  • [41] Repurposing of the macrolide antibiotic clarithromycin for the prevention of lung cancer.
    Moghaddam, Seyed Javad
    Hussain, Tabish
    Zarghooni, Melody
    Velasco, Walter V.
    Phan, Linda
    Savage, Michelle I.
    Fox, Jennifer T.
    Sei, Shizuko
    Brown, Powel H.
    Aldaz, C. Marcelo
    CANCER PREVENTION RESEARCH, 2022, 15 (12)
  • [42] Repurposing statins for prevention of triple-negative breast cancer
    Bhardwaj, Anjana
    Singh, Harpreet
    Rajapakshe, Kimal
    Coarfa, Cristian
    Bedrosian, Isabelle
    CANCER RESEARCH, 2017, 77
  • [43] Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
    Ahmed Olatunde
    Manisha Nigam
    Rahul Kunwar Singh
    Abhaya Shikhar Panwar
    Abdulwahab Lasisi
    Fahad A. Alhumaydhi
    Vijay Jyoti kumar
    Abhay Prakash Mishra
    Javad Sharifi-Rad
    Cancer Cell International, 21
  • [44] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [45] Repurposing cancer drugs to treat neurological diseases–Src inhibitors as examples
    Da Zhi Liu
    NeuralRegenerationResearch, 2017, 12 (06) : 910 - 911
  • [46] Mechanism based repurposing of neurodegenerative disease drugs for breast cancer treatment
    Nair, Rakesh Sathish
    Das, Subhasis
    Sondarva, Gautam
    Viswakarma, Navin
    Fuller, Kascha
    Ibrahimi, Lucas
    Rana, Basabi
    Rana, Ajay
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S17 - S17
  • [47] Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent
    Sukhatme, Vidula
    Bouche, Gauthier
    Meheus, Lydie
    Sukhatme, Vikas P.
    Pantziarka, Pan
    ECANCERMEDICALSCIENCE, 2015, 9
  • [48] Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?
    Pantziarka, Pan
    Bouche, Gauthier
    Meheus, Lydie
    Sukhatme, Vidula
    Sukhatme, Vikas P.
    FUTURE ONCOLOGY, 2015, 11 (02) : 181 - 184
  • [49] Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives
    Lianos, Georgios D.
    Alexiou, George A.
    Rausei, Stefano
    Galani, Vasiliki
    Mitsis, Michail
    Kyritsis, Athanasios P.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 131 - 134
  • [50] Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
    Bibby, Becky A. S.
    Thiruthaneeswaran, Niluja
    Yang, Lingjian
    Pereira, Ronnie R.
    More, Elisabet
    McArt, Darragh G.
    O'Reilly, Paul
    Bristow, Robert G.
    Williams, Kaye J.
    Choudhury, Ananya
    West, Catharine M. L.
    BMC UROLOGY, 2021, 21 (01)
12345